Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies
- PMID: 19223536
- PMCID: PMC2666963
- DOI: 10.1158/0008-5472.CAN-08-3515
Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies
Erratum in
- Cancer Res. 2009 Jun 15;69(12):5267. Gate, Margaret A [corrected to Gates, Margaret A]
Abstract
Prior studies have suggested that vitamin D may reduce ovarian cancer risk. Thus, we examined whether three single nucleotide polymorphisms (SNP) in the vitamin D receptor (VDR) gene (Fok1, Bsm1, Cdx2) were associated with risk of epithelial ovarian cancer in a retrospective case-control study (New England Case-Control study, NECC) and a nested case-control study of three prospective cohort studies: the Nurses' Health Study (NHS), NHSII, and the Women's Health Study. Data from the cohort studies were combined and analyzed using conditional logistic regression and pooled with the results from the NECC, which were analyzed using unconditional logistic regression, using a random effects model. We obtained genotype data for 1,473 cases and 2,006 controls. We observed a significant positive association between the number of Fok1 f alleles and ovarian cancer risk in the pooled analysis (P(trend) = 0.03). The odds ratio (OR) for the ff versus FF genotype was 1.26 [95% confidence interval (CI) = 1.01-1.57]. Neither the Bsm1 (P(trend) = 0.96) or Cdx2 (P(trend) = 0.13) SNPs were significantly associated with ovarian cancer risk. Among the prospective studies, the risk of ovarian cancer by plasma vitamin D levels did not clearly vary by any of the genotypes. For example, among women with the Fok1 FF genotype, the OR comparing plasma 25-hydroxyvitamin D >or=32 ng/mL versus <32 ng/mL was 0.66 (95% CI, 0.34-1.28), and among women with the Ff or ff genotype the OR was 0.71 (95% CI, 0.43-1.18). Our results of an association with the Fok1 VDR polymorphism further support a role of the vitamin D pathway in ovarian carcinogenesis.
Figures

Similar articles
-
Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk.Prostate. 2007 Jun 15;67(9):911-23. doi: 10.1002/pros.20570. Prostate. 2007. PMID: 17440943
-
Associations between polymorphisms in the vitamin D receptor and breast cancer risk.Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2335-9. doi: 10.1158/1055-9965.EPI-05-0283. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 16214913
-
Vitamin D Receptor Polymorphisms and Cancer.Adv Exp Med Biol. 2020;1268:53-114. doi: 10.1007/978-3-030-46227-7_4. Adv Exp Med Biol. 2020. PMID: 32918214
-
A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.PLoS Med. 2007 Mar;4(3):e103. doi: 10.1371/journal.pmed.0040103. PLoS Med. 2007. PMID: 17388667 Free PMC article. Clinical Trial.
-
The Association Between VDR and GC Polymorphisms and Lung Cancer Risk: A Systematic Review and Meta-Analysis.Genet Test Mol Biomarkers. 2020 May;24(5):285-295. doi: 10.1089/gtmb.2019.0187. Epub 2020 Apr 7. Genet Test Mol Biomarkers. 2020. PMID: 32255717
Cited by
-
Vitamin D and VDR gene polymorphism (FokI) in epithelial ovarian cancer in Indian population.J Ovarian Res. 2013 May 26;6(1):37. doi: 10.1186/1757-2215-6-37. J Ovarian Res. 2013. PMID: 23705897 Free PMC article.
-
The Cdx-2 polymorphism in the VDR gene is associated with increased risk of cancer: a meta-analysis.Mol Biol Rep. 2013 Jul;40(7):4219-25. doi: 10.1007/s11033-013-2503-9. Epub 2013 May 7. Mol Biol Rep. 2013. PMID: 23649760
-
Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer.Br J Cancer. 2009 Dec 15;101(12):1957-60. doi: 10.1038/sj.bjc.6605414. Epub 2009 Nov 10. Br J Cancer. 2009. PMID: 19904266 Free PMC article.
-
Vitamin D receptor gene polymorphisms and uterine fibroid incidence in Caucasian women.Arch Med Sci. 2019 Jan 30;17(6):1643-1650. doi: 10.5114/aoms.2019.81748. eCollection 2021. Arch Med Sci. 2019. PMID: 34900044 Free PMC article.
-
Associations between serum vitamin D and the risk of female reproductive tumors: A meta-analysis with trial sequential analysis.Medicine (Baltimore). 2018 Apr;97(15):e0360. doi: 10.1097/MD.0000000000010360. Medicine (Baltimore). 2018. PMID: 29642181 Free PMC article.
References
-
- Anderson MG, Nakane M, Ruan X, Kroeger PE, Wu-Wong JR. Expression of VDR and CYP24A1 mRNA in human tumors. Cancer Chemother Pharmacol. 2006;57:234–40. - PubMed
-
- Saunders DE, Christensen C, Lawrence WD, et al. Receptors for 1,25-dihydroxyvitamin D3 in gynecologic neoplasms. Gynecol Oncol. 1992;44:131–6. - PubMed
-
- Ahonen MH, Zhuang YH, Aine R, Ylikomi T, Tuohimaa P. Androgen receptor and vitamin D receptor in human ovarian cancer: growth stimulation and inhibition by ligands. Int J Cancer. 2000;86:40–6. - PubMed
-
- Friedrich M, Rafi L, Mitschele T, Tilgen W, Schmidt W, Reichrath J. Analysis of the vitamin D system in cervical carcinomas, breast cancer and ovarian cancer. Recent Results Cancer Res. 2003;164:239–46. - PubMed
-
- Villena-Heinsen C, Meyberg R, Axt-Fliedner R, Reitnauer K, Reichrath J, Friedrich M. Immunohistochemical analysis of 1,25-dihydroxyvitamin-D3-receptors, estrogen and progesterone receptors and Ki-67 in ovarian carcinoma. Anticancer Res. 2002;22:2261–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA050385/CA/NCI NIH HHS/United States
- P01 CA087969/CA/NCI NIH HHS/United States
- R01 CA067262/CA/NCI NIH HHS/United States
- R01 HL043851/HL/NHLBI NIH HHS/United States
- CA49449/CA/NCI NIH HHS/United States
- CA67262/CA/NCI NIH HHS/United States
- R25 CA098566/CA/NCI NIH HHS/United States
- P01 CA87969/CA/NCI NIH HHS/United States
- R01 HL080467/HL/NHLBI NIH HHS/United States
- U01 CA049449/CA/NCI NIH HHS/United States
- P50 CA105009/CA/NCI NIH HHS/United States
- U01 CA067262/CA/NCI NIH HHS/United States
- R01 CA047988/CA/NCI NIH HHS/United States
- HL-080467/HL/NHLBI NIH HHS/United States
- R01 CA049449/CA/NCI NIH HHS/United States
- CA-47988/CA/NCI NIH HHS/United States
- CA50385/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical